List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 16 studies with search of:   "Telik" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: TLK286 in combination with docetaxel
2 Recruiting Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)
Condition: Myelodysplastic Syndrome (MDS)
Intervention: Drug: Ezatiostat Hydrochloride
3 Completed TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
Condition: Ovarian Neoplasms
Interventions: Drug: TLK286 HCl for injection;   Drug: topotecan hydrochloride for injection;   Drug: doxorubicin HCl liposome injection
4 Completed Phase 2 Study of TLK286 in Platinum Resistant Advanced Epithelial Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Drug: TLK286
5 Completed Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS)
Condition: Myelodysplastic Syndrome (MDS)
Intervention: Drug: Ezatiostat Hydrochlorine
6 Completed Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: TLK286
7 Completed Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Condition: Non Small Cell Lung Carcinoma
Interventions: Drug: TLK286 (Telcyta) HCl for Injection;   Drug: gefitinib (Iressa)
8 Completed Phase 2 Study of TLK286 in Metastatic Breast Cancer
Condition: Breast Neoplasms
Intervention: Drug: TLK286
9 Completed TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Drug: TLK286
10 Active, not recruiting Ph 3 Randomized Study of Telcyta® + Liposomal Doxorubicin Vs Liposomal Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer
Condition: Ovarian Neoplasms
Interventions: Drug: TLK286 (Telcyta) HCI for Injection;   Drug: Doxorubicin HCI Liposome Injection
11 Active, not recruiting Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: TLK286;   Drug: carboplatin;   Drug: paclitaxel
12 Completed TLK286 in Combination With Doxil in Platinum Refractory or Resistant Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Drug: TLK286
13 Completed Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
Condition: Myelodysplastic Syndromes
Intervention: Drug: TLK199 HCl Liposomes for Injection
14 Recruiting Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non‑Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: Ezatiostat Hydrochloride
15 Completed TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer
Condition: Ovarian Neoplasms
Interventions: Drug: TLK286 (Telcyta) HCI for Injection;   Drug: Carboplatin, Paraplatin for Injection;   Drug: Doxorubicin HCI Liposome Injection
16 Completed TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: TLK286, cisplatin

  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services